Literature DB >> 4812769

Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.

J A Gottlieb, S E Rivkin, S C Spigel, B Hoogstraten, R M O'Bryan, F C Delaney, A Singhakowinta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4812769     DOI： 10.1002/1097-0142(197402)33:2<519::aid-cncr2820330229>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  16 in total

1.  Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.

Authors:  J Mattern; M Kaufmann; H Hinderer; K Wayss; M Volm
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975

2.  Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.

Authors:  E A Eisenhauer; K I Pritchard; D J Perrault; S Verma; J L Pater
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

3.  Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting.

Authors:  B Rotman; C Teplitz; K Dickinson; J P Cozzolino
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

4.  Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment.

Authors:  W Scheithauer; C Zielinksi; H Ludwig
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Site-dependent response to chemotherapy for carcinoma of the breast.

Authors:  J M Whitehouse
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

6.  Three model shapes of Doxorubicin for liposome encapsulation.

Authors:  Kanes Sumetpipat; Duangkamon Baowan
Journal:  J Mol Model       Date:  2014-11-06       Impact factor: 1.810

7.  Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.

Authors:  A Sulkes; E Gez; M R Pfeffer; R Catane; R Isacson; S Biran
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.

Authors:  H T Mouridsen; M Cornbleet; R Stuart-Harris; I Smith; R Coleman; R Rubens; M McDonald; H Rainer; A van Oosterom; J Smyth
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 9.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

Review 10.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.